Table 1 The correlation between the expression of CCAT1 and clinicopathologic characteristics in GC patients (N = 90)
From: LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement
Parameters | Expression of CCAT1 in GC tissues | p-value | |
|---|---|---|---|
Low (%) | High (%) | ||
Age/year | Â | Â | 0.338 |
 < 60 | 13 (34) | 25 (66) |  |
 ≥ 60 | 23 (44) | 29 (56) |  |
Gender | Â | Â | 0.021* |
 Male | 25 (34) | 48 (66) |  |
 Female | 11 (65) | 6 (35) |  |
Smoking | Â | Â | 0.297 |
 No | 18 (46) | 21 (54) |  |
 Yes | 18 (35) | 33 (65) |  |
Drink | Â | Â | 0.605 |
 No | 18 (43) | 24 (57) |  |
 Yes | 18 (38) | 30 (62) |  |
Family history | Â | Â | 0.217 |
 No | 23 (36) | 41 (64) |  |
 Yes | 13 (50) | 13 (50) |  |
Tumor size | Â | Â | 0.478 |
 ≤ 5 cm | 24 (43) | 32 (57) |  |
 > 5 cm | 12 (35) | 22 (65) |  |
Lymph node | Â | Â | 0.043* |
 Negative | 16 (55) | 13 (45) |  |
 Positive | 20 (33) | 41 (67) |  |
TNM Stage | Â | Â | 0.005* |
 I-II | 19 (59) | 13 (41) |  |
 III-IV | 17 (29) | 41 (71) |  |
Tumor thrombus | |||
 Negative | 28 (49) | 29 (51) | 0.020* |
 Positive | 8 (24) | 25 (76) |  |
Neural invasion | |||
 Negative | 21 (48) | 23 (52) | 0.143 |
 Positive | 15 (33) | 31 (67) |  |